| Identification | Back Directory | [Name]
6-(2-Carboxyethyl)-7-oxo-8-(1-deoxo-D-ribose-1-yl)-7,8-dihydropteridine-2,4(1H,3H)-dione | [CAS]
29161-67-9 | [Synonyms]
Putidolumazine
6-Carboxyethyl-7-oxo-8-ribityllumazine
1,2,3,4,7,8-Hexahydro-2,4,7-trioxo-8-(1-deoxy-D-ribitol-1-yl)pteridine-6-propionic acid
6-(2-Carboxyethyl)-7-oxo-8-(1-deoxo-D-ribose-1-yl)-7,8-dihydropteridine-2,4(1H,3H)-dione
1-[6-(2-Carboxyethyl)-1,3,4,7-tetrahydro-2,4,7-trioxopteridin-8(2H)-yl]-1-deoxy-D-ribitol
8-[(2S,3S,4R)-2,3,4,5-Tetrahydroxypentyl]-2,4,7-trioxo-1,2,3,4,7,8-hexahydropteridine-6-propionic acid | [MOL File]
29161-67-9.mol |
| Hazard Information | Back Directory | [Uses]
Photolumazine I(PLI) is a vitamin B-based hapten.Photolumazine Icanactivates Mucosal-associated Invariant T clones[1]. | [References]
[1] Corbett AJ,et al. Antigen Recognition by MR1-Reactive T Cells; MAIT Cells, Metabolites, and Remaining Mysteries. Front Immunol. 2020;11:1961. Published 2020 Aug 27. DOI:10.3389/fimmu.2020.01961 |
|
|